Professor Carter paints a fascinating picture of the historical use of leeches, their management and their recycling (January 2001 JRSM, pp. 38±42). In plastic and reconstructive surgery today we still use leeches. Their resurgence in popularity is due largely to the work of Dr Roy Sawyer, founder of Biopharm, the ®rst leech farm in the world, situated just outside Swansea in South Wales 1 . Contemporary plastic surgeons have described various uses including assisting the venous drainage of free¯aps and augmenting the microcirculation in replanted digits 2, 3 .
Carter discusses some of the problems the Victorians found and these should be considered in their use today. Each leech will extract about 5±10 mL of blood from a wound, and then 40±50 mL of blood may be lost from the bite itself after removal. If prolonged leeching is contemplated to allow the venous circulation to re-establish itself and multiple leech applications are performed, then a substantial amount of blood can be lost. If the patient is a child, and even if a digit is leeched, one should keep a close check on the haemoglobin.
Secondly, there have been several reports of infection from leech bites. This may prejudice reconstruction and one should consider antibiotic prophylaxis during their application. The organism Aeromonas hydrophila is essential for the leech to digest blood and grow and has been implicated in infection following the use of medicinal leeches 4 .
To update the narrative to the twenty-®rst century, all the information needed to keep and use leeches can now be found on the Biopharm website at [www.biopharmleeches.com]. Regarding the low-dose helical computed tomography (CT) being evaluated by the Early Lung Cancer Action Group, it should be noted that some 50% of lung cancer cases develop within the bronchial tree. It is unlikely such a tumour would be identi®ed by low-dose CT at an early stage; some other methods would be needed to diagnose such tumours. I was therefore surprised that no reference is made in the article to¯uorescence bronchoscopy which, when combined with proper sampling and the use of histological and molecular methods, has been shown to have great potential in the screening of high-risk individuals 1 , particularly when combined with sputum cytology. Whilst this method does not ful®l the criteria for an ideal screening test, it does offer a way forward. Several pilot studies are already in progress throughout the world, including one at the Yorkshire Laser Centre. 
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